Jupiter is actively exploring additional strategic partnerships to expand JOTROL’s application across other neuroinflammatory and metabolic disorders, including Alzheimer’s disease and longevity ...

HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of ...

Tuberculosis remains one of the top infectious disease killers worldwide, a challenge amplified by drug-resistant forms of the disease.

A U.S. Army veteran who served in the war in Afghanistan has pleaded not guilty to fatally shooting a homeless man with an ...

Kennedy casts himself as “anti-establishment,” but he doesn’t object to the cruel profit-driven health care system that ...

Many Americans support prohibiting commercials for prescription drugs on television. But enacting that ban could be ...

The global humidity sensor market is expected to be valued at USD 3.44 billion in 2025 and is projected to reach USD 4.64 ...

Teva Pharmaceutical Industries reported a slightly larger than expected rise in fourth-quarter profit, helped by double-digit ...

Daal, Brand Director at Pharmapack shares her views on the pharmaceutical packaging sector, the latest industry trends that were witnessed at Pharmapack Europe, Europe's leading packaging and drug ...

Modern global regulatory bodies should draw upon the repertoire of strategies used by their 1930s predecessors to survive ...

Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...